• Français
• Site Map
• Glossary
• Contact Us
• Home

• About DiagnoCure
  • Mission and History
  • Board of Directors
  • Management
  • Advisory Board
  • Intellectual Property
• Investors
  • Overview
  • Q&A
  • Financial Information
  • Press Releases
  • Strategy
  • Management
  • Presentations
  • Analysts
  • Corporate Governance
  • Investors Contact
• News and Events
  • Overview
  • Press Releases
  • Events
  • News Alerts
  • Media Room
• Products and Projects
  • Overview
  • Highlights on Cancer
  • Molecular Diagnostics
  • Prostate Cancer
  • Colorectal Cancer
  • Breast Cancer
  • Bladder Cancer
  • Other R&D Projects
  • Useful Links
• Customer Service
• Career
  • A Career of Passion
  • Talent Wanted

Products and Projects

Cancer diagnostic tests

Utilizing innovative methods, DiagnoCure is focused on the development and commercialization of molecular diagnostic tests for the detection and management of cancer.

The following table shows the Company’s main products and projects.

ASR (Analyte Specific Reagent): Commercialization of test components for sale by reference laboratories under their label and responsibility with an FDA allowance.

IVD (In Vitro Diagnostic): Commercialization of the test for direct sale by DiagnoCure and/or its partners with an FDA approval.

LDT (Laboratory Developed Test): Test that is developped and validated by a certified clinical laboratory, and offered directly to physicians.